Cargando…

ADVERSE EVENTS TO FIRST LINE ANTI-TUBERCULOSIS DRUGS IN PATIENTS CO-INFECTED WITH HIV AND TUBERCULOSIS

BACKGROUND: The combination and use of multiple drugs in the treatment of tuberculosis (TB) predispose to adverse drug events and reactions. This study evaluated the incidence, frequency, and severity of adverse events to first line anti-tuberculosis (anti-TB) drugs in patients with TB and co-infect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michael, O.S., Sogaolu, O.M., Fehintola, F.A., Ige, O.M., Falade, C.O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Association of Resident Doctors (ARD), University College Hospital, Ibadan 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049598/ https://www.ncbi.nlm.nih.gov/pubmed/27721682

Ejemplares similares

Analysis of Adverse Drug Reactions to First-Line Anti-Tuberculosis Drugs Using the Korea Adverse Event Reporting System
por: Chung, Soo Jie, et al.
Publicado: (2022)

Pulmonary tuberculosis among health care workers at two designated DOTS Centers in urban city of Ibadan, Nigeria
por: Kehinde, A.O., et al.
Publicado: (2011)

COMPARATIVE EFFICACY AND SAFETY OF CEFIXIME AND CIPROFLOXACIN IN THE MANAGEMENT OF ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN IBADAN, NIGERIA
por: Ige, O.M., et al.
Publicado: (2015)

PERSISTENCE OF PLASMODIUM FALCIPARUM HRP2 ANTIGEN AFTER EFFECTIVE ANTIMALARIAL THERAPY
por: Michael, O.S., et al.
Publicado: (2021)

PERSPECTIVE: SUSTAINING EFFECTIVE MALARIA CONTROL DURING THE COVID-19 PANDEMIC
por: Michael, O.S., et al.
Publicado: (2021)

Intrapulmonary Pharmacokinetics of First-line Anti-tuberculosis Drugs in Malawian Patients With Tuberculosis
por: McCallum, Andrew D, et al.
Publicado: (2020)

First Susceptibility Testing of Mycobacterium tuberculosis for Second-line Anti-tuberculosis Drugs in Ghana
por: Kato, Tomoko, et al.
Publicado: (2014)

The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
por: Ezati, Nicholas, et al.
Publicado: (2014)

First and Second-Line Anti-Tuberculosis Drug-Resistance Patterns in Pulmonary Tuberculosis Patients in Zambia
por: Monde, Ngula, et al.
Publicado: (2023)

Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs
por: Sanchotene, Karine O., et al.
Publicado: (2008)

Comparison of Mycobacterium tuberculosis drug susceptibility using solid and liquid culture in Nigeria
por: Lawson, Lovett, et al.
Publicado: (2013)

ASSESSMENT OF SOCIOECONOMIC STATUS AND CONTROL OF ASTHMA IN ADULTS
por: Azeez, I.A., et al.
Publicado: (2016)

Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs
por: Kumar, Agibothu Kupparam Hemanth, et al.
Publicado: (2017)

Atopy is a risk factor for adult asthma in urban community of Southwestern Nigeria
por: Ige, O. M., et al.
Publicado: (2012)

Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients
por: Tetteh, Raymond A., et al.
Publicado: (2016)

Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case
por: Osei-Wusu, Stephen, et al.
Publicado: (2018)

Magnitude of Phenotypic and MTBDRplus Line Probe Assay First-Line Anti-Tuberculosis Drug Resistance Among Tuberculosis Patients; Northwest Ethiopia
por: Yigzaw, Wubet Birhan, et al.
Publicado: (2021)

The effects of first-line anti-tuberculosis drugs on the actions of vitamin D in human macrophages
por: Chesdachai, Supavit, et al.
Publicado: (2016)

Determinants of serum concentration of first-line anti-tuberculosis drugs from China
por: Lei, Qian, et al.
Publicado: (2019)

Analysis of prevalence of adverse events connected with anti-tuberculosis drugs during pregnancy: A meta-analysis
por: Wu, Diqing, et al.
Publicado: (2023)

Two cases of culture proven Mycobacterium tuberculosis presenting with a broad-complex tachycardia and non-caseating granulomas
por: Farah, Z., et al.
Publicado: (2014)

The Distribution Pattern of First-Line Anti-Tuberculosis Drug Concentrations between the Blood and the Vertebral Focus of Spinal Tuberculosis Patients
por: Jiang, Guanyin, et al.
Publicado: (2022)

Adverse drug reaction prevalence and mechanisms of action of first-line anti-tubercular drugs
por: Imam, Faisal, et al.
Publicado: (2020)

A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs
por: Daskapan, Alper, et al.
Publicado: (2018)

Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid
por: Jiang, Yuhan, et al.
Publicado: (2021)

Low Resistance to First and Second Line Anti-Tuberculosis Drugs among Treatment Naive Pulmonary Tuberculosis Patients in Southwestern Uganda
por: Orikiriza, Patrick, et al.
Publicado: (2015)

The burden of adverse events during treatment of drug-resistant tuberculosis in Namibia
por: Sagwa, Evans, et al.
Publicado: (2012)

Optimal Sampling Strategies for Therapeutic Drug Monitoring of First-Line Tuberculosis Drugs in Patients with Tuberculosis
por: Saktiawati, Antonia Morita I., et al.
Publicado: (2019)

Phenotypically Adapted Mycobacterium tuberculosis Populations from Sputum Are Tolerant to First-Line Drugs
por: Turapov, Obolbek, et al.
Publicado: (2016)

First line anti-tuberculosis induced hepatotoxicity: incidence and risk factors
por: Bouazzi, Omaima El, et al.
Publicado: (2016)

Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort study
por: Merid, Mehari Woldemariam, et al.
Publicado: (2019)

Knowledge about tuberculosis, treatment adherence and outcome among ambulatory patients with drug-sensitive tuberculosis in two directly-observed treatment centres in Southwest Nigeria
por: Adisa, Rasaq, et al.
Publicado: (2021)

First-Line Anti-Tubercular Drug Resistance of Mycobacterium tuberculosis in IRAN: A Systematic Review
por: Pourakbari, Babak, et al.
Publicado: (2016)

High occurrence of simultaneous multiple-drug hypersensitivity syndrome induced by first-line anti-tuberculosis drugs()
por: Sim, Da Woon, et al.
Publicado: (2021)

Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016–2018
por: Buziashvili, Mariana, et al.
Publicado: (2021)

Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis
por: Wu, Chunli, et al.
Publicado: (2023)

Monitoring Linked Epidemics: The Case of Tuberculosis and HIV
por: Sánchez, María S., et al.
Publicado: (2010)

Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study
por: Cox, Helen, et al.
Publicado: (2021)

Severe Cutaneous Adverse Reactions to Anti-tuberculosis Drugs in Korean Patients
por: Jin, Hyun Jung, et al.
Publicado: (2020)

Adverse Events in Treating Smear-Positive Tuberculosis Patients in China
por: Zhang, Tao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6db8j9s38uu1lv7akj6n5auumi